Cite
MLA Citation
Johann S de Bono et al.. “Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.” Lancet oncology, vol. 22, no. 9, 2021, pp. 1250–1264. http://access.bl.uk/ark:/81055/vdc_100144484216.0x000031